common shares

Kane Biotech (TSX‑V: KNE) announced a non‑brokered private placement of up to 16 million common shares at $0.05 each, seeking up to $800,000 in gross proceeds. Funds will support working capital and general corporate needs, including its revyve® wound‑care platform. Insiders may participate. Closing is expected around December 17 2025, subject to TSX Venture Exchange approval, and all shares will be subject to a four‑month‑plus‑one‑day lock‑up. The offering is not registered in the United States and cannot be sold to U.S. persons.

Orosur Mining (TSX:OMI/AIM:OMI) announced a C$20 million private placement expected to close on October 2, 2025. The offering includes up to 58,823,530 new common shares. Additionally, 260,000 common shares were issued following consultant option exercises, and 8,675,418 shares were issued from warrant exercises, raising US$701,894. Post-these issuances, Orosur will have 325,758,894 common shares in issue, with 4,701,668 options and 22,834,404 warrants outstanding.

Civista Bancshares (NASDAQ: CIVB) priced an offering of 3.29 million common shares at $21.25 each, aiming to raise ~$70 million. With an underwriters’ option, proceeds could reach $80.5 million. The capital, expected to close July 14, will fund organic growth and potential acquisitions in Midwest markets. Piper Sandler leads the transaction under Civista’s existing SEC shelf registration.